- AU$30.65m
- AU$24.15m
- AU$4.05m
Australia Stock Exchange release from EMYRIA : Half Yearly Report and Accounts
Australia Stock Exchange release from EMYRIA : Emyria grows its novel MDMA-analogue library
Australia Stock Exchange release from EMYRIA : PRE_NR Ends: 10:04:06
Australia Stock Exchange release from EMYRIA : General Meeting Adjourned - Letter to Shareholders
Australia Stock Exchange release from EMYRIA : Application for quotation of securities - EMD
Australia Stock Exchange release from EMYRIA : Release of securities from escrow
Australia Stock Exchange release from EMYRIA : Notice under section 708A(5)(e) of the Corporations Act
Australia Stock Exchange release from EMYRIA : Application for quotation of securities - EMD
Australia Stock Exchange release from EMYRIA : Appendix 4C - Quarterly
Australia Stock Exchange release from EMYRIA : PRE_NR Ends: 10:03:28
Australia Stock Exchange release from EMYRIA : Letter to Shareholders - General Meeting
Australia Stock Exchange release from EMYRIA : Notice of General Meeting/Proxy Form
Australia Stock Exchange release from EMYRIA : Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD
Australia Stock Exchange release from EMYRIA : PRE_NR Ends: 09:52:28
Australia Stock Exchange release from EMYRIA : Proposed issue of securities - EMD
Australia Stock Exchange release from EMYRIA : Emyria appoints Sixty Two Capital as corporate advisor
Australia Stock Exchange release from EMYRIA : Notice under section 708A(5)(e) of the Corporations Act
Australia Stock Exchange release from EMYRIA : Application for quotation of securities - EMD
Australia Stock Exchange release from EMYRIA : Change of Registry Address